Screener
ImmunityBio, Inc. IBRX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from ImmunityBio, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
FAQ
- What is ImmunityBio, Inc.'s operating margin?
- ImmunityBio, Inc. (IBRX) reported operating margin of -185.4% in Q1 2026.
- How has ImmunityBio, Inc.'s operating margin changed year-over-year?
- ImmunityBio, Inc.'s operating margin increased by 81.5% year-over-year, from -1,003.8% to -185.4%.
- What is the long-term trend for ImmunityBio, Inc.'s operating margin?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s operating margin has grown at a -60.6% compound annual growth rate (CAGR), from -23,852.7% to -226%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about ImmunityBio, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude